Active not recruiting

A Study of Galcanezumab (LY2951742) in Participants With Episodic Migraine

I5Q-MC-CGAX - ClinicalTrials.gov - NCT03963232

The reason for this study is to see if the drug galcanezumab is safe and effective in participants with episodic migraine.
How long will I be in the trial?
The study will last about 53 weeks and may include up to 12 visits.
Email
Active not recruiting

A Study of Galcanezumab (LY2951742) in Participants With Episodic Migraine

I5Q-MC-CGAX - ClinicalTrials.gov - NCT03963232

The reason for this study is to see if the drug galcanezumab is safe and effective in participants with episodic migraine.
How long will I be in the trial?
The study will last about 53 weeks and may include up to 12 visits.
Email

Key Requirements

Age :

18-65

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18-65

Sex

All

Participants must

Participants must have a diagnosis of migraine, with a history of migraine headaches of at least 1 year prior to screening and migraine onset prior to age 50

Participants must have a history of 4-14 migraine headache days and at least 2 migraine attacks per month on average within the past 3 months

Participants must NOT

Participants must not be currently enrolled in any other clinical trial

Participants must not be taking or have taken galcanezumab or another CGRP antibody

Participants must not be taking, or are expected to take, therapeutic antibodies

Participants must not be allergic to multiple drugs or certain types of drugs sometimes used for headaches

Participants must not be pregnant or nursing

Participants must not have have a history of chronic migraine, daily persistent headache, cluster headache, medication overuse headache, migraine with brainstem aura, or hemiplegic migraine

Trial Summary

Conditions the trial is for

Migraine

What the trial is testing?

Galcanezumab, Placebo

Could I receive a Placebo?

yes

Enrollment Goal

486

Trial Dates

July 2019 - February 2022

Trial Phase

3

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18-65

Sex

All

Participants must

Participants must have a diagnosis of migraine, with a history of migraine headaches of at least 1 year prior to screening and migraine onset prior to age 50

Participants must have a history of 4-14 migraine headache days and at least 2 migraine attacks per month on average within the past 3 months

Participants must NOT

Participants must not be currently enrolled in any other clinical trial

Participants must not be taking or have taken galcanezumab or another CGRP antibody

Participants must not be taking, or are expected to take, therapeutic antibodies

Participants must not be allergic to multiple drugs or certain types of drugs sometimes used for headaches

Participants must not be pregnant or nursing

Participants must not have have a history of chronic migraine, daily persistent headache, cluster headache, medication overuse headache, migraine with brainstem aura, or hemiplegic migraine

Trial Summary

Conditions the trial is for

Migraine

What the trial is testing?

Galcanezumab, Placebo

Could I receive a Placebo?

yes

Enrollment Goal

486

Trial Dates

July 2019 - February 2022

Trial Phase

3

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Migraine Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?